Assessing intra- and interfraction motion and its dosimetric impacts on cervical cancer adaptive radiotherapy based on 1.5T MR-Linac

Table 1 Patient characteristics

	Values
Years	median: 52 range: 33–74
Staging
IB	7 (22.0%)
II	5 (16.0%)
III	1 (3.0%)
IIIB	2 (6.0%)
IIIC	14 (44.0%)
IVB	1 (3.0%)
stage unknown	2 (6.0%)
Pathological classification
squamous cell carcinoma	23 (72.0%)
adenocarcinoma	7 (22.0%)
mixed carcinoma	2 (6.0%)

IMRT: Intensity-modulated radiotherapy. UCC staging followed the criteria established by the Federation International of Gynecology and Obstetrics (FIGO) [31]

ISSN: 1748-717X